Processa Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance
Processa Pharmaceuticals, Inc. (PCSA) had Deferred Tax Assets, Net of Valuation Allowance of $2.15 million as of 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-03-30
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.15M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.90M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.12M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $733.56K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2021-12-31 | $2.15M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.90M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $1.12M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $733.56K 10-K · filed 2020-03-06 | |
| 2016-12-31 | $5.07M 10-K · filed 2017-09-25 | |
| 2015-12-31 | $4.99M 10-K · filed 2017-09-25 | $5.15M 10-K · filed 2017-06-19 |
| 2014-12-31 | $3.56M 10-K · filed 2017-06-19 | $117.28K 10-K · filed 2015-04-14 |
| 2013-12-31 | $66.63K 10-K · filed 2015-04-14 | |
| 2012-12-31 | $134.39K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |